Pulmonary Hypertension in Left Heart Disease (PH-LHD) Differentiation Index

Clinical calculation support · Verify results before clinical use

Clinical input panel

Enter clinical and echocardiographic findings. Outputs include the published H2FPEF score, a clearly labelled non-validated feature count, and optional interpretation of an externally calculated OPTICS score.

3Outputs
Used for H2FPEF and PH-LHD-associated feature count.
The OPTICS derivation specified prior valvular surgery without residual left-sided valvular disease.
Count medications, not drug classes, according to the H2FPEF definition used in the source.
Enter the sum of S-wave depth in V1 and R-wave height in V6.
Source definition included LAVI >34 mL/m² or a qualitative description of dilation.
Enter only if already calculated using the published weighted OPTICS system. A threshold of ≥104 was reported to be highly specific but insensitive for postcapillary PH.

How to interpret the outputs

This tool combines the published H2FPEF score with selected clinical, ECG, and echocardiographic features associated with postcapillary pulmonary hypertension. These outputs answer different questions and should not be conflated.

H2FPEF score

ComponentCriterionPoints
HeavyBMI >30 kg/m²2
Hypertension treatment≥2 antihypertensive medications1
Atrial fibrillationPresent3
Pulmonary hypertensionEcho PASP >35 mmHg1
ElderAge >60 years1
Filling pressureE/e′ >91

Score bands

TotalUsual interpretation
0–1Low likelihood of HFpEF
2–5Intermediate likelihood; consider further evaluation as clinically appropriate
6–9High likelihood of HFpEF

PH-LHD-associated features

The feature count lists BMI ≥30, diabetes, atrial fibrillation, dyslipidemia, left atrial dilation, SV1 + RV6 ≥35 mm, and prior left-sided valvular surgery. The published OPTICS model assigns a specific weighted point system; this simple count is not equivalent and has not been validated as a score.

Clinical context and limitations

The OPTICS study evaluated non-invasive prediction of elevated pulmonary artery wedge pressure in patients with pulmonary hypertension who lacked clear signs of left-sided heart disease. At the prespecified OPTICS cutoff of ≥104, specificity was 100% and sensitivity was 22% in the reported external validation cohort.

  • A high OPTICS score may support suspicion for postcapillary PH, but the low sensitivity means a score below threshold cannot exclude it.
  • A high H2FPEF score supports HFpEF likelihood but does not independently classify PH as postcapillary.
  • Prior valvular surgery should be interpreted in context, particularly whether residual left-sided valve disease is present.
  • PAH and PH-LHD classification requires a complete clinical assessment; right-heart catheterization and hemodynamic measurements may be necessary.

References

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA.A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction. Circulation. 2018;138:861–870. DOI: 10.1161/CIRCULATIONAHA.118.034646; PMID: 29792299.
Jansen SMA, et al.Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score. J Am Heart Assoc. 2020;9:e015992. DOI: 10.1161/JAHA.119.015992; PMID: 32750312.
Clinical disclaimer: This educational decision-support tool does not establish a diagnosis or replace professional judgment, guideline-directed evaluation, or invasive hemodynamic assessment when indicated. Verify source definitions, measurements, and the OPTICS weighted score before clinical use.